Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordant.

Scuderi S, Tin AL, Marra G, Bianchi L, Kesch C, Soeterik TFW, Ploussard G, Zattoni F, Ettala O, Røder A, Poyet C, Stroomberg HV, Cimmino U, Fiard G, Nordström T, Patel HD, Gupta GN, Yonover PM, Guillaume B, Gaffney C, Zhuang J, Wang Y, Sarkis J, Jabbour T, Diamand R, Windisch O, Olivier J, Abbadi A, Kim EH, Wang JC, Hu J, Zhu A, Stabile A, Eastham JA, Montorsi F, Briganti A, Gandaglia G, Vickers AJ